Schall Thomas J. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Schall Thomas J. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $101K.

Profile

Thomas J. Schall is a member of the board of directors of Immuneering Corp (IMRX), as disclosed in the SEC filing dated January 20, 2026. Immuneering is a biopharmaceutical company focused on translational bioinformatics and computational biology to enhance drug discovery. The filing notes Schall as a director with no reported securities purchases or sales in Immuneering at that time.

Board memberships

• Immuneering Corp

Awards & honors

• Serves on the board of directors of Immuneering Corp, contributing to governance and strategic oversight

Recent Transactions

Companies — Last 90 Days

• Immuneering Corp (IMRX) — 1 filings, last 2026-06-11

Frequently Asked Questions

Who is Schall Thomas J.?

Thomas J. Schall is a member of the board of directors of Immuneering Corp (IMRX), as disclosed in the SEC filing dated January 20, 2026. Immuneering is a biopharmaceutical company focused on translational bioinformatics and computational biology to enhance drug discovery. The filing notes Schall as a director with no reported securities purchases or sales in Immuneering at tha…

How many SEC Form 4 filings has Schall Thomas J. submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Schall Thomas J. been buying or selling stock?

Recorded transactions: 1 open-market purchases ($101K) and 0 open-market sales () across all tracked filings.

Where can I see all of Schall Thomas J.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week